Common GLP-1 medications include: Wegovy (semaglutide) Zepbound (tirzepatide) These medications work by: Slowing stomach emptying Reducing hunger and cravings Improving insulin sensitivity For many patients, GLP-1 therapy leads to 1520% total body-weight loss , particularly when combined with nutrition and lifestyle changes
We used linear mixed and fixed effects regression models to understand the effects of exercise and GLP-1 on heart rate and heart rate variability when accounting for individual user differences, weekday and weekend effects
Age-Related Increases in Benign Paroxysmal Positional Vertigo Are Reversed in Women Taking Estrogen Replacement Therapy: A Population-Based Study in Taiwan
Quick summary for GPs Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist approved in New Zealand for chronic weight management
Additional results of the meta-analysis showed GLP-1 medications reduced all-cause mortality by 12% and hospital admission for heart failure by 11% in type 2 adult patients
Another possible explanation is that larger adipocytes cause a failure to recruit new adipocytes, thus diminishing the expandability of AT and resulting in IR by a lipotoxic mechanism [31]